analyst
NASDAQ · ELVN
Enliven Therapeutics, Inc.
Healthcare · Biotechnology
$54.32
Down-$1.91 (-3.40%)
Updated Sep 14, 2026, 5:57 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.11B
- P/E ratio
- -9.76
- Dividend yield
- 0.00%
- 52-week range
- $26.70 – $62.32
- Volume
- 995.82K
- Avg. volume
- 581.23K
Price performance
ELVN price history
1M range · 19 trading sessions · Daily adjusted prices
ELVN closed at $54.32 after 19 trading sessions, down 8.76% for the selected period.
- Last close
- $54.32
- Period change
- -8.76%
- Period low
- $54.32
- Period high
- $61.15
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $57.00 | $57.00 | $54.12 | $54.32 | 995.82K |
| Sep 10, 2026 | $57.15 | $57.82 | $56.05 | $56.23 | 769.64K |
| Sep 9, 2026 | $59.05 | $59.96 | $57.29 | $57.45 | 1.29M |
| Sep 8, 2026 | $58.75 | $59.90 | $58.24 | $59.37 | 1.33M |
| Sep 4, 2026 | $59.69 | $59.89 | $58.965 | $59.32 | 1.11M |
| Sep 3, 2026 | $58.875 | $60.10 | $58.66 | $59.65 | 806.07K |
| Sep 2, 2026 | $58.36 | $60.55 | $57.36 | $59.01 | 609.97K |
| Sep 1, 2026 | $57.99 | $58.45 | $57.23 | $57.86 | 1.06M |
| Aug 31, 2026 | $57.50 | $58.785 | $56.33 | $57.89 | 982.05K |
| Aug 28, 2026 | $60.40 | $61.18 | $57.73 | $57.86 | 584.98K |
| Aug 27, 2026 | $60.76 | $61.82 | $60.46 | $60.50 | 524.07K |
| Aug 26, 2026 | $61.025 | $61.80 | $59.79 | $60.865 | 1M |
| Aug 25, 2026 | $61.90 | $62.00 | $60.57 | $61.01 | 804.39K |
| Aug 24, 2026 | $59.77 | $61.99 | $59.47 | $61.15 | 1.26M |
| Aug 21, 2026 | $59.00 | $60.00 | $58.83 | $59.82 | 596.37K |
| Aug 20, 2026 | $58.95 | $59.535 | $57.07 | $58.92 | 945.52K |
| Aug 19, 2026 | $61.01 | $61.21 | $58.39 | $59.39 | 939.74K |
| Aug 18, 2026 | $59.79 | $60.44 | $59.01 | $60.07 | 619.31K |
| Aug 17, 2026 | $58.71 | $59.65 | $57.915 | $59.535 | 529.48K |
Latest ELVN news
The latest Smart Investors Daily articles mentioning ELVN.
Stock researchResearch & News · SID Coverage
Loading stock research…